An Open Phase II Study To Evaluate The Efficacy And Toxicity Of Topotecan Administered Intravenously As Five Daily Infusions Every 21 Days To Women With Advanced Epithelial Ovarian Carcinoma

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A double-blind, between patient, multicentre study comparing the efficacy, tolerability and effects on cognitive function of paroxetine with those of lofepramine in depressed patients in general practice

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Double-Blind, Imipramine- and Placebo-Controlled Study of Paroxetine in Depressed Outpatients

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Double-Blind Feasibility Study to Estimate and Compare the Effect of Rosiglitazone in Parallel with Glyburide on Cognition in Patients with Type 2 Diabetes Mellitus

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

An Investigation of the Effect of Rosiglitazone Maleate (BRL 49653C) Versus Troglitazone on the Safety, Tolerability and Pharmacokinetics of Triazolam in Healthy Volunteers

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Phase IIb controlled randomised double-blind study to evaluate the efficacy, safety and immunogenicity of SmithKline Beecham Biologicals’ candidate RTS,S malaria vaccine in semi-immune adult males in The Gambia

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

An Open Phase I Study to Determine the Maximal Tolerated Dose of Topotecan HCl Administered Intravenously as a Single Dose Every 21 Days in Patients with Solid Tumors Refractory to All Known Forms of Effective Therapy

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A phase I/II trial of an investigational vaccination regimen in infants

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Effect of lacidipine and losartan on 24 hour systolic blood pressure variability in elderly hypertensive patients, a pilot study

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Meta-Analysis Plan for an analysis to compare the addition of Umeclidinium Inhalation Powder 62.5mcg to ICS/LABA with Placebo plus ICS/LABA in subjects with Chronic Obstructive Pulmonary Disease (COPD)

• Pays Aucun
• Organes Aucun
• Spécialités Aucune